Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC39808 Didesmethylrocaglamide Didesmethylrocaglamide 是一种 Rocaglamide 的衍生物,也是一种有效的真核起始因子 4A (eIF4A) 抑制剂。Didesmethylrocaglamide 具有有效的生长抑制活性,IC50 为 5 nM。Didesmethylrocaglamide 抑制多种促进生长的信号通路,并诱导肿瘤细胞凋亡 (apoptosis)。抗肿瘤活性。
  3. GC39798 Scoulerine

    金黄紫堇碱,(-)-Scoulerine; Discretamine

    A benzylisoquinoline alkaloid with diverse biological activities
  4. GC39719 Nigericin

    尼日利亚霉素

    A potassium ionophore

  5. GC39708 DT2216 DT2216 是一种蛋白水解靶向嵌合体 (PROTAC),靶向 Bcl-xL 降解依赖于 Bcl-2 家族过表达蛋白(例如 Bcl-2、Bcl-xL 和 Mcl)的 T 细胞淋巴瘤-1.DT2216 抑制 G-68 细胞,IC50 值为 4.02 μM(72 小时)。
  6. GC39707 Droloxifene

    屈洛昔芬,3-Hydroxytamoxifen

    A selective estrogen receptor modulator
  7. GC39699 Aurintricarboxylic acid

    金精三羧酸

    A protein synthesis inhibitor with diverse biological activities
  8. GC39640 GPLGIAGQ TFA

    GPLGIAGQ TFA 是一种 MMP2 可切割的多肽,在脂质体和胶束纳米载体中都被用作刺激敏感的连接物,用于 MMP2 触发的肿瘤靶向治疗。GPLGIAGQ TFA可用于合成光动力治疗 (PDT) 中独特的 MMP2 靶向光敏剂。

  9. GC39620 AKOS-22 AKOS-22 是一种有效的线粒体蛋白电压依赖性阴离子通道 1 (VDAC1) 抑制剂 (Kd=15.4 μM)。AKOS-22 与 VDAC1 相互作用,抑制 VDAC1 齐聚和凋亡。AKOS-22 对线粒体功能的保护作用。
  10. GC39584 AGN194204

    IRX4204; NRX194204; VTP 194204

    AGN194204 (IRX4204) 是一种具有口服活性的,选择性 RXR 激动剂,对 RXRα,RXRβ 和 RXRγ 的 Kd 值分别为 0.4 nM,3.6 nM 和 3.8 nM,EC50 分别为 0.2 nM,0.8 nM 和 0.08 nM。AGN194204 对 RAR 无活性,并具有抗炎和抗癌作用。
  11. GC39556 CDDO-3P-Im CDDO-3P-Im 是 CDDO 咪唑胺类似物,具有化学预防作用。CDDO-3P-Im 可降低小鼠肺癌模型肺肿瘤的大小和严重程度。
  12. GC39555 CDDO-2P-Im CDDO-2P-Im 是 CDDO 咪唑胺类似物,具有化学预防作用。CDDO-2P-Im 可降低小鼠肺癌模型肺肿瘤的大小和严重程度。
  13. GC39551 BRD3308 An HDAC3 inhibitor
  14. GC39535 Yamogenin

    雅姆皂甙元; Neodiosgenin

    A steroidal sapogenin with diverse biological activities
  15. GC39503 PROTAC FKBP Degrader-3 PROTAC FKBP Degrader-3 是一种包含 FKBP 配体结合基团,linker 和 VHL 结合基团的 PROTAC。PROTAC FKBP Degrader-3 是一种有效的 FKBP 降解剂。
  16. GC39500 PDK4-IN-1 hydrochloride PDK4-IN-1 hydrochloride 是一种蒽醌衍生物,也是一种有效的,口服活性的丙酮酸脱氢酶激酶 4 (PDK4) 抑制剂,IC50 值为 84 nM。PDK4-IN-1 hydrochloride 有效抑制细胞转化和细胞增殖并诱导细胞凋亡 (apoptosis)。PDK4-IN-1 hydrochloride 具有抗糖尿病,抗癌和抗过敏作用。
  17. GC39489 GPNA hydrochloride

    Γ-(P-硝基苯胺)-L-谷氨酸盐酸盐

    GPNA hydrochloride作为γ-谷氨酰转移酶(GGT)的底物,可抑制谷氨酰胺(Gln)转运蛋白ASCT2的活性,IC50为250μM。
  18. GC39485 CK2/ERK8-IN-1 A dual inhibitor of CK2 and ERK8
  19. GC39483 BO-264 A TACC3 inhibitor
  20. GC39450 Tea polyphenol

    茶多酚

    Tea polyphenols are chemical compounds such as flavanoids and tannins found naturally in tea. Several biological properties have been associated to tea polyphenols (TP), including antioxidant, anti-carcinogenic and antimicrobial activities.
  21. GC39415 OR-1896

    左西孟旦杂质

    OR-1896 是 Levosimendan 的活性长寿代谢产物。OR-1896 是一种高选择性磷酸二酯酶 (PDE III) 抑制剂,是一种功能强大的血管扩张剂。OR-1896 可以打开 ATP 敏感的 K+ 通道,并具有 Ca2+ 致敏作用。OR-1896 可减轻心肌细胞的凋亡,心脏重塑和心肌炎症。
  22. GC39382 FW1256 FW1256 是一种苯基类似物,也是一种缓释硫化氢 (H2S) 供体。FW1256 抑制 NF-κB 活性,并可诱导细胞凋亡 (apoptosis),并可用于癌症,炎症和心血管疾病的研究。
  23. GC39377 EB-3D EB-3D is a potent and selective inhibitor of choline kinase α (ChoKα) with IC50 of 1 μM for ChoKα1. EB-3D induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells.
  24. GC39365 CPTH2 A HAT inhibitor
  25. GC39355 BTSA1 BTSA1 is a pharmacologically optimized BAX activator that binds with high affinity and specificity to the N-terminal activation site and induces conformational changes to BAX leading to BAX-mediated apoptosis. It effectively promotes apoptosis in leukemia cell lines and patient samples while sparing healthy cells.
  26. GC18416 ONO-7475

    ONO-7475

    An inhibitor of Axl and Mer
  27. GC50517 OD 36 hydrochloride OD 36 hydrochloride是一种强效的RIPK2激酶抑制剂,IC50值为5.3nM。
  28. GC50482 (D)-PPA 1 An inhibitor of the PD-1-PD-L1 protein-protein interaction
  29. GC50465 A 410099.1

    N-甲基-L-丙氨酰-(2S)-2-环己基氨基乙酰基-N-[(1R)-1,2,3,4-四氢-1-萘基]-L-脯氨酰胺盐酸盐

    High affinity XIAP antagonist; active in vivo
  30. GC50372 SK 216 Plasminogen activator inhibitor-1 (PAI-1) inhibitor
  31. GC50368 INF 4E INF 4E 是一种有效的 NLRP3 炎性体抑制剂。
  32. GC50296 D9

    D9 是一种有效的选择性硫氧还蛋白还原酶 (TrxR) 抑制剂,EC50 为 2.8 nM。 D9 具有在体外和体内抑制肿瘤增殖的能力。

  33. GC50282 EC 19 Synthetic retinoid; induces differentiation of stem cells
  34. GC50280 JX 06

    NSC 402538

    An irreversible PDHK inhibitor
  35. GC50253 PF 543 hydrochloride

    Sphingosine Kinase 1 Inhibitor II hydrochloride

    A potent inhibitor of SPHK1
  36. GC50242 RA 839 RA 839 是 Keap1 的非共价小分子结合剂,Kd 约为 6 μM,是 Nrf2 信号传导的选择性激活剂。
  37. GC50223 MSC 2032964A Potent and selective ASK1 inhibitor; orally bioavailable
  38. GC50196 Simvastatin - d6

    六氘代辛伐他汀,MK 733-d6

    An internal standard for the quantificaition of simvastatin
  39. GC50190 Fenretinide - d4

    4-HPR-d4, 4-Hydroxy(phenyl)retinamide-d4, Retinoic Acid p-hydroxyphenylamide-d4

    An internal standard for the quantification of fenretinide
  40. GC50141 SMBA 1 High affinity and selective activator of Bax
  41. GC50118 S 07662 Constitutive androstane receptor (CAR) inverse agonist
  42. GC50112 NCL 00017509 A Nek2 inhibitor
  43. GC50109 AZD 5582 dihydrochloride A Smac mimetic and IAP inhibitor
  44. GC50063 rac-CCT 250863 rac-CCT 250863 (compound rac-21) 是一种选择性和可逆的 NEK 2 抑制剂,IC50 为 0.073 µM。 rac-CCT 250863 表现出良好的诱导细胞周期停滞的作用,并且还可以在细胞中进行抗增殖(Pomalidomide 敏感/抗性)。 rac-CCT 250863 与 Pomalidomide 结合时可诱导细胞凋亡。
  45. GC50045 PD 166285 dihydrochloride

    6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮盐酸盐

    A tyrosine kinase inhibitor
  46. GC50009 LY 294002 hydrochloride Prototypical PI 3-kinase inhibitor; also inhibits other kinases
  47. GC39302 PARP14 inhibitor H10 PARP14 inhibitor H10 (化合物 H10) 是针对 PARP14 的选择性抑制剂 (IC50=490 nM),是其他 PARP 的抑制剂 (约为 PARP1 的 24 倍)。PARP14 抑制剂 H10 诱导 caspase-3/7 介导的细胞凋亡 (apoptosis)。
  48. GC39296 1G244 1G244 是一种有效的 DPP8/9 抑制剂,IC50 分别为 12 nM 和 84 nM,但不抑制 DPPIV 和 DPPII。1G244 可诱导多发性骨髓瘤细胞凋亡,并具有抗骨髓瘤作用。
  49. GC39295 DJ001 DJ001 是一种高度特异性,选择性和非竞争性的蛋白酪氨酸磷酸酶-σ (PTPσ) 抑制剂,IC50 为 1.43 μM。DJ001 对其他磷酸酶无抑制活性,对蛋白质磷酸酶 5 仅有中等抑制活性。DJ001 促进造血干细胞再生。
  50. GC39281 (R)-CR8 trihydrochloride

    CR8, (R)-Isomer trihydrochloride

    An inhibitor of cyclin-dependent kinases
  51. GC39266 Hematein

    氧化苏木精

    Hematein inhibits casein kinase II activity in a selective, dose-dependent and ATP non-competitive manner in vitro, with IC50 of 0.55 μM in the presence of 10 μM ATP.

Items 1051 to 1100 of 2721 total

per page

Set Descending Direction